Precision Medicine Diagnostics Market Share to See Modest Growth Through 2026

Precision Medicine Diagnostics Market Size,
Share, Trend, Outlook, Future Growth
Analysis And Synthesis 2018 - 2026
Precision medicine aims to alter the treatments based on individual characteristics, including differences
in genetics, environment, and lifestyle. It has the potential to transform the delivery of care for a
variety of diseases. Precision medicine implicate the application of panomic analysis and systems biology
to inspect the cause of an individual patient's diseased condition at the molecular level and then to
apply targeted treatments to address that individual patient's disease. Precision medicine aims to make
medication and medical practices efficient and cost effective. By using the precision medicine, doctors
recognize genetic makeup of the subject, which helps doctors to prescribe the right drug with
appropriate dose.
Request Sample of Report:
Precision Medicine Diagnostics Market- Drivers
Precision medicine diagnostics market is expected to expand at rapid pace in near future, owing to
increasing number of pipeline studies to develop new treatment for cancer. For instance, in January
2016, University of Arkansas initiated the clinical trial for fresh tissue biopsy to study the further
advancements in bio-specimens (blood cellular free component, e.g., plasma, serum, tissue, urine), in
order to develop precision medicine for lung cancer management and screening (synergy with imaging).
Fresh tissue biopsy involves taking a small sample of tissue from the body part for further microscopic
examination. The study is estimated to complete in December 2019.
Precision Medicine Diagnostics Market- Regional Analysis
On the basis of region, the global precision medicine diagnostics market is segmented into North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Geographically, North America accounts for the largest share in the global precision medicine diagnostics
market, owing to increasing awareness and initiative related to precision medicine in the North America.
For instance, in 2015, the U.S Government launched the Precision Medicine Initiative to revolutionize
method to improve health and treat disease. The precision medicine initiative will enable health care
providers to adapt new treatment and prevention strategies to people’s unique characteristics, including
their genome sequence, micro-biome composition, health history, lifestyle, and diet.
Report includes chapters which deeply display the following deliverable about industry :
• Cardiovascular Drugs Market Research Objective and Assumption
• Cardiovascular Drugs Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Cardiovascular Drugs Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Cardiovascular Drugs Market, By Regions
• Cardiovascular Drugs Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Cardiovascular Drugs Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Cardiovascular Drugs Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Cardiovascular Drugs Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Precision Medicine Diagnostics Market- Key Players
Some of the major players operating in the precision medicine diagnostics market include Intomics,
Ferrer Incode, Nanostring Technologies, Inc., Tepnel Pharma Services, Pfizer, Inc., Novartis AG, Teva
Pharmaceuticals, Merck & Co., Inc., Qiagen N.V., and Quest Diagnostics.
Precision Medicine Diagnostics Market- Taxonomy
By Technology:
Gene Sequencing
Drug Discovery
Precision Molecular Diagnostics
Big Data Analytics
By Application:
Breast cancers
Lung Cancer
Browse In-Depth Analysis Research Report:
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Precision medicine diagnostics market is expected to expand at rapid pace in near future, owing to increasing number of pipeline studies to develop new treatment for cancer.